Pharmacielo Ltd
- LAST PRICE0.1800
- TODAY'S CHANGE (%)0.0050 (2.8571%)
- Bid / Lots0.1750/ 5
- Ask / Lots0.1800/ 8
- Open / Previous Close0.1800 / 0.1750
- Day Range
- 52 Week Range
- Volume502,065
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PCLO |
|---|---|---|
| 09:38 ET | 2500 | 0.18 |
| 11:00 ET | 1500 | 0.185 |
| 12:18 ET | 18500 | 0.17 |
| 12:36 ET | 8500 | 0.17 |
| 12:41 ET | 1000 | 0.17 |
| 12:43 ET | 1000 | 0.17 |
| 12:45 ET | 1000 | 0.17 |
| 12:56 ET | 10000 | 0.17 |
| 12:57 ET | 27000 | 0.17 |
| 01:06 ET | 1000 | 0.17 |
| 01:10 ET | 1000 | 0.17 |
| 01:28 ET | 1000 | 0.17 |
| 02:02 ET | 93500 | 0.17 |
| 02:31 ET | 3000 | 0.17 |
| 02:44 ET | 500 | 0.18 |
Apr 10, 2024
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors, from 7:46AM ET on Wednesday Apr 10, 2024 by Dow Jones
7:46AM ET on Wednesday Apr 10, 2024 by Dow Jones
Mar 26, 2024
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil, from 7:31AM ET on Tuesday Mar 26, 2024 by Dow Jones
7:31AM ET on Tuesday Mar 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pharmacielo Ltd | 30.5M | -2.2x | --- |
Red Light Holland Corp | 23.6M | -4.1x | --- |
Mountain Valley MD Holdings Inc | 18.1M | -2.4x | --- |
Nass Valley Gateway Ltd | 15.6M | -9.0x | --- |
Eastwood Bio-Medical Canada Inc | 47.5M | -89.5x | --- |
RIV Capital Inc | 14.2M | -0.2x | --- |
Company Information
PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.
Contact Information
- Headquarters
- 82 Richmond Street EastTORONTO, ON, Canada M5C 1P1
- Phone
- 416-315-8741
- Fax
- 416-315-8741
Executives
- Chairman of the Board, Chief Executive Officer
- Marc Lustig
- Chief Financial Officer, Director
- Ian Atacan
- Chief Operating Officer
- Andres Botero
- Lead Independent Director
- William Petron
- Independent Director
- Douglas Bache
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $30.5M |
|---|---|
Revenue (TTM) | $2.8M |
Shares Outstanding | 169.7M |
Pharmacielo Ltd does not pay a dividend. | |
Beta | 2.49 |
EPS | $-0.08 |
Book Value | $0.04 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 10.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -430.74% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
